Dedicated Healthcare Investors with Global Reach

Founded in 2013, Oberland Capital is a dedicated healthcare investment firm with approximately $3.5 billion in assets under management. We specialize in flexible investment structures for clinical-stage and commercial-stage companies, customized to meet the specific strategic and financial objectives of our partners. At Oberland Capital, we employ a fundamental, research-driven approach coupled with quantitative methods to identify and invest in innovative technologies that have the potential to substantially improve the lives of patients worldwide. Our partners include public and private companies, research institutions, and individual inventors.

At Oberland Capital, we focus on investing in the pharmaceutical, biotechnology, medical device, and diagnostic industries. We work collaboratively with management teams to develop creative structures that meet their specific needs, enabling them to access significant amounts of capital to pursue a variety of objectives, including accelerating R&D, expanding commercial infrastructure, acquiring new assets or companies, and refinancing or supplementing existing capital sources. We have the experience, scale, and reach to execute structured investments globally.